Sigma’s CSO joins PharmX Board


Strategic alliance sees Sigma’s chief strategy officer, Mark Conway, appointed to the board of PharmX Technologies  Following the announcement of a five-year partnership, which will see Sigma Healthcare take a 10% stake in PharmX, the wholesaler has announced its nominee to sit on the technology firm’s board.   In a statement to the Australian Securities Exchange (ASX) on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous dRx series: Deprescribing estrogens in older people
Next Full scope services need owner buy-in: Twomey